These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25735322)

  • 1. Plasma phosphoproteome and differential plasma phosphoproteins with opisthorchis viverrini-related cholangiocarcinoma.
    Kotawong K; Thitapakorn V; Roytrakul S; Phaonakrop N; Viyanant V; Na-Bangchang K
    Asian Pac J Cancer Prev; 2015; 16(3):1011-8. PubMed ID: 25735322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Peptidome as a Source of Biomarkers for Diagnosis of Cholangiocarcinoma.
    Kotawong K; Thitapakorn V; Roytrakul S; Phaonakrop N; Viyanant V; Na-Bangchang K
    Asian Pac J Cancer Prev; 2016; 17(3):1163-8. PubMed ID: 27039742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Potential Biomarkers for
    Aksorn N; Roytrakul S; Kittisenachai S; Leelawat K; Chanvorachote P; Topanurak S; Hamano S; Lek-Uthai U
    In Vivo; 2018; 32(4):871-878. PubMed ID: 29936472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma checkpoint protein 1 (Chk1) as a potential diagnostic biomarker for opisthorchiasis and cholangiocarcinoma.
    Phanaksri T; Yingchutrakul Y; Roytrakul S; Prasopdee S; Kunjantarachot A; Butthongkomvong K; Tesana S; Sathavornmanee T; Thitapakorn V
    Cancer Biomark; 2022; 33(1):43-55. PubMed ID: 34366327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel carbohydrate antigen expression during development of Opisthorchis viverrini- associated cholangiocarcinoma in golden hamster: a potential marker for early diagnosis.
    Sawanyawisuth K; Silsirivanit A; Kunlabut K; Tantapotinan N; Vaeteewoottacharn K; Wongkham S
    Parasitol Int; 2012 Mar; 61(1):151-4. PubMed ID: 21784171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator.
    Silakit R; Loilome W; Yongvanit P; Chusorn P; Techasen A; Boonmars T; Khuntikeo N; Chamadol N; Pairojkul C; Namwat N
    J Hepatobiliary Pancreat Sci; 2014 Dec; 21(12):864-72. PubMed ID: 25131257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wound healing and cancer progression in Opisthorchis viverrini associated cholangiocarcinoma.
    Botelho MC; Alves H; Richter J
    Parasitol Res; 2016 Jul; 115(7):2913-4. PubMed ID: 27130317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta as a potential biomarker for
    Prasopdee S; Yingchutrakul Y; Roytrakul S; Pholhelm M; Phanaksri T; Kunjantarachot A; Kulsantiwong J; Butthongkomvong K; Tesana S; Sathavornmanee T; Thitapakorn V
    Parasitology; 2022 Feb; 149(2):171-180. PubMed ID: 35234600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secreted Opisthorchis viverrini glutathione S-transferase regulates cell proliferation through AKT and ERK pathways in cholangiocarcinoma.
    Daorueang D; Thuwajit P; Roitrakul S; Laha T; Kaewkes S; Endo Y; Thuwajit C
    Parasitol Int; 2012 Mar; 61(1):155-61. PubMed ID: 21782971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholangiocarcinoma in experimental hamsters with long-standing Opisthorchis viverrini infection.
    Songserm N; Prasongwattana J; Sithithaworn P; Sripa B; Pipitkool V
    Asian Pac J Cancer Prev; 2009; 10(2):299-302. PubMed ID: 19537899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: a potential molecular marker for tumor metastasis.
    Loilome W; Wechagama P; Namwat N; Jusakul A; Sripa B; Miwa M; Kuver R; Yongvanit P
    Parasitol Int; 2012 Mar; 61(1):136-9. PubMed ID: 21763455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma.
    Sudsarn P; Boonmars T; Ruangjirachuporn W; Namwat N; Loilome W; Sriraj P; Aukkanimart R; Nadchanan W; Jiraporn S
    Pathol Oncol Res; 2016 Jan; 22(1):57-65. PubMed ID: 26277607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinoma.
    Boonjaraspinyo S; Wu Z; Boonmars T; Kaewkes S; Loilome W; Sithithaworn P; Nagano I; Takahashi Y; Yongvanit P; Bhudhisawasdi V
    Parasitol Int; 2012 Mar; 61(1):145-50. PubMed ID: 21777692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Protein Expression Marks the Transition From Infection With
    Khoontawad J; Pairojkul C; Rucksaken R; Pinlaor P; Wongkham C; Yongvanit P; Pugkhem A; Jones A; Plieskatt J; Potriquet J; Bethony J; Pinlaor S; Mulvenna J
    Mol Cell Proteomics; 2017 May; 16(5):911-923. PubMed ID: 28232516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis to identify plasma orosomucoid 2 and kinesin 18A as potential biomarkers of cholangiocarcinoma.
    Rucksaken R; Khoontawad J; Roytrakul S; Pinlaor P; Hiraku Y; Wongkham C; Pairojkul C; Boonmars T; Pinlaor S
    Cancer Biomark; 2012; 12(2):81-95. PubMed ID: 23396253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTHFR polymorphisms and Opisthorchis viverrini infection: a relationship with increased susceptibility to cholangiocarcinoma in Thailand.
    Songserm N; Promthet S; Sithithaworn P; Pientong C; Ekalaksananan T; Chopjitt P; Parkin DM
    Asian Pac J Cancer Prev; 2011; 12(5):1341-5. PubMed ID: 21875294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA profiling of exosomes derived from plasma and their potential as biomarkers for Opisthorchis viverrini-associated cholangiocarcinoma.
    Supradit K; Wongprasert K; Tangphatsornruang S; Yoocha T; Sonthirod C; Pootakham W; Thitapakorn V; Butthongkomvong K; Phanaksri T; Kunjantarachot A; Klongprateeppon H; Sattavacharavech P; Prasopdee S
    Acta Trop; 2024 Oct; 258():107362. PubMed ID: 39151716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma.
    Yongvanit P; Pinlaor S; Loilome W
    J Hepatobiliary Pancreat Sci; 2014 May; 21(5):309-15. PubMed ID: 24408859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum antibody response to Opisthorchis viverrini antigen as a marker for opisthorchiasis-associated cholangiocarcinoma.
    Akai PS; Pungpak S; Chaicumpa W; Viroj K; Bunnag D; Befus AD
    Trans R Soc Trop Med Hyg; 1994; 88(4):471-4. PubMed ID: 7570848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subsets of Inflammatory Cytokine Gene Polymorphisms are Associated with Risk of Carcinogenic Liver Fluke
    Surapaitoon A; Suttiprapa S; Mairiang E; Khuntikeo N; Pairojkul C; Bethony J; Brindley PJ; Sripa B
    Korean J Parasitol; 2017 Jun; 55(3):295-304. PubMed ID: 28719954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.